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CASE REPORT
Aorto-subclavian thromboembolism: a rare complication
associated with moderate ovarian hyperstimulation
syndrome
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The case of an arterial aorto-subclavian thromboembolism
associated with a moderate ovarian hyperstimulation syn-
drome (OHSS) and following ovulation induction for in-
vitro fertilization in a young woman is reported. Because
of the lack of response to systemic thrombolysis, a left
postero-lateral thoracotomy was performed on day 8 after
embryo transfer. A fibrinocruoric embolus situated at the
junction of the left subclavian artery from the aorta was
removed through a left subclavian arteriotomy. The distal
axillary embolus was removed by a retrograde balloon
catheter embolectomy. A moderate OHSS was observed.
The ovarian stimulation and OHSS-related risks of thrombo-
embolism are discussed. We conclude that, in the absence of
risk factors, counselling about possible complications
resulting from stimulation must be emphasized.
Key words: arterial thromboembolism/IVF/menotrophin/
ovarian hyperstimulation syndrome
Introduction
Ovarian hyperstimulation syndrome (OHSS) is the most fre-
quent and worrying complication following ovulation induc-
tion. The incidence of this side-effect has increased since
gonadotrophin releasing hormone analogues (GnRHa) have
been used. For many authors, the different protocols which
associate follicle stimulating hormone (FSH) and/or human
menopausal gonadotrophin (HMG) with GnRHa seem to be
related to a significantly higher rate of moderate or severe
OHSS (Rizk and Smitz, 1992). Some authors (Rabau et al,
1967) have classified ovarian response in three clinical cat-
egories (mild, moderate and severe) and six grades (two per
category) based on the severity of the signs, symptoms and
laboratory findings. The more recent definition of OHSS
proposed by Golan et al. (1989) has offered a more clinical
approach to this syndrome. Severe complications of this
iatrogenic syndrome include thromboembolism, adult respira-
tory distress syndrome, acute hydrothorax (Daniel et al, 1995)
and, occasionally, death (Schenker and Ezra, 1994). During
ovarian stimulation for in-vitro fertilization (TVF) and embryo
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transfer, the risk of moderate or severe OHSS after GnRHa/
HMG stimulation is evaluated as 0.6-14.0% (Rizk and Smitz,
1992). We report the case of. an arterial aorto-subclavian
thromboembolism associated with a moderate OHSS in a
young woman.
Case report
A non-Caucasian 32 year old woman was treated in our IVF
and embryo transfer programme for a secondary infertility
associated with a male factor and a bilateral tubal obstruction.
Her past medical history reported a right salpingectomy for
an ectopic pregnancy and a proximal left tubal occlusion. A
mild essential hypertension was easily corrected with labetalol
(200 mg/day).
The treatment procedure consisted of a long protocol (Figure
1). After pituitary desensitization with GnRHa (0.1 mg Deca-
peptyl; Ferring, Zurich, Switzerland) administered from day
23, multiple follicular development was induced using
225 IU HMG (Pergonal; Serono, Aubonne, Switzerland) daily.
Follicular growth was monitored with serial ultrasound scans
and repeated estimations of oestradiol blood concentrations.
On day 10 of stimulation, the HMG dose was reduced
to 150 IU because of the high oestradiol concentration
(10.5 nmol/1). By day 12, 11 follicles >16 mm in diameter and
16 smaller follicles were observed. The oestradiol concentration
reached 17.8 nmol/1 when 10 000 IU human chorionic gonado-
trophin (HCG; Profasi; Serono) were administered. Oocyte
recovery took place 36 h later. In all, 18 oocytes were collected;
12 oocytes fertilized, three embryos were transferred to the
uterus 2 days later and nine embryos were frozen. A dose of
1000 IU HCG was given i.m. on the day of embryo transfer
and 48 h later for luteal phase support. This support was
stopped because the patient complained of nausea and
abdominal tension. No diarrhoea or vomiting was noticed.
Abdominal ultrasonography showed enlarged ovaries (9 cm).
As expected, multiple ovarian cysts and a small quantity of
ascites were found. The haemoglobin concentration was
139 g/1, with a haematocrit of 0.44. Electrolytes and creatinine
concentrations were within the normal range. A diagnosis of
moderate OHSS was made, based on clinical, laboratory and
echographic findings. On day 6 after transfer, the patient began
to complain of pain and paraesthesia in the left arm which she
had noticed 36 h earlier. Examination revealed pulseless radial
and humeral arteries and a cold left arm. The aetiology of die
acute ischaemia was determined by an arteriography, which
showed a large clot in the left subclavian artery (Figure 2)
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Figure 1. Chronology of events.
and an occlusion of the left axillary artery. Signs of slight
haemoconcentration were present (haemoglobin 151 g/1, haem-
atocrit 0.46). Clotting function tests were within the normal
range [quick time (FT), partial thrombin time (PTT)]. As
thrombolysis was initiated as an emergency procedure, more
specific thrombosis risk factors such as protein C, protein S,
Leiden V factor and antithrombin HI deficiencies were not
checked. Immediate local thrombolysis was attempted with
100 000 and 200 000 IU urokinase without success. Anti-
coagulation using i.v. heparin and oral aspirin was initiated.
Given the lack of response, a left postero-lateral thoracotomy
was performed on day 7 after transfer. Surgical exploration
revealed a fibrinocruoric embolus situated at the junction of
the left subclavian artery with the aorta. The embolus was
removed through a left subclavian arteriotomy. The distal
axillary embolus was removed by a retrograde balloon catheter
embolectomy. The presence of a patent foramen oval (para-
doxical emboli) was excluded during the operation by using a
transoesophageal echocardiography with microbubbles test.
The choice of this surgical strategy was motivated by the
danger of left carotid arterial emboli after the use of retrograde
balloon catheter embolectomy from the left humeral artery. At
the end of the operation, the left radial artery was again
palpable. Heparin administration was discontinued and di-
coumarol administration introduced after the existence of a
pregnancy had been excluded.
Discussion
Arterial thromboembolism is a rare complication of OHSS.
Only 11 cases of arterial thrombosis have been described
following gonadotrophin stimulation: two cases of right middle
cerebral artery thrombosis (Neau et aL, 1989; Rizk et aL,
1990), one of cerebral anterior artery thrombosis (Dumont
et aL, 1980), one of vertebral artery thrombosis (Humbert
et aL, 1973), three of internal carotid artery thrombosis (Mozes
et aL, 1965; Kermode et aL, 1993; Aurousseau et aL, 1995),
one of humeral artery thrombosis (Aurousseau et aL, 1995),
one of unilateral femoral artery thrombosis (Mozes et aL,
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Figure 2. Selective angiogram of left subclavian artery showing
proximal occlusion by a fibrinocruoric embolus and distal axillary
obstruction. A radiological steal subclavian syndrome occurred.
1965), one of bilateral femoral artery thrombosis (Choktanasiri
and Rojanasakul, 1995) and one of popliteal artery thrombosis
(Aurousseau et aL, 1995). Most of these occlusions are
characterized by their position in the superior limb or in the
cerebral territory. The case reported here shows an unusual
location of thrombosis occurring during a moderate OHSS.
No risk factor for thromboembolism had been detected,
either by clinical observation or by cardiological and laboratory
investigations performed before the treatment Three OHSS
risk factors were present: a high oestradiol concentration
induced by the simultaneous administration of GnRHa with
HMG, ovulation induction with HCG and the use of HCG as
a luteal phase support Only one of the previously described
cases of arterial thrombosis presents all these risk factors
(Table I).
In our reported case, OHSS risk was, in our opinion, not
sufficient to cancel HCG administration or to avoid embryo
transfer. In our practice, the cycle is cancelled when the
oestradiol concentration is >20 nmol/1 or when the number
of follicles >16 mm in diameter is >12. This attitude is
supported by Morris et al. (1995). Our patient did not develop
severe OHSS, although the retrospectively calculated predic-
tion rate according to Delvigne et al. (1993) was 78.9%.
Many factors contribute to thrombogenesis during the evolu-
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Table I. Menotrophins and gonadotrophin-releasing hormone analogue (GnRHa) use in the 11 reviewed cases of arterial thrombosis associated with ovarian
hyperstimulation syndrome
References Thrombosis location HMG GnRHa HCG
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
ND
ND
ND
No
No
No
Yes
Ovulation induction
Yes
Yes
Yes
Yes
ND
ND
ND
Yes
Yes
Yes
Yes
Luteal support
No
No
No
No
ND
ND
ND
Yes
No
Yes
Yes
Rizk« al. (1990)
Kermode el al. (1993)
Mozes et al. (1965)
Mozes et al. (1965)
Aurousseau et al. (1995)
Aurousseau et al. (1995)
Aurousseau et al. (1995)
Dumont et al. (1980)
Neau et al. (1989)
Humberts al. (1973)
Choktanasiri and Rojanasakul (1995)
Middle cerebral artery
Internal carotid artery
Internal carotid artery
Unilateral femoral artery
Internal carotid artery
Humeral artery
Popliteal artery
Cerebral anterior artery
Middle cerebral artery
Vertebral artery
Bilateral femoral artery
HCG = human chorionic gonadotrophin; HMG = human menopausal gonadotrophin; ND = not described.
tion of an OHSS. Some of these seem to be relatively non-
specific and related to fluid shifting from the vascular space
to the extracellular space. As demonstrated by McClure et al
(1994), capillary permeability increases during spontaneous or
induced ovulation, mainly caused by a vascular endothelial
growth factor (VEGF). Usually, the angiogenesis of spon-
taneous ovulation is self-limited to one follicle. In the context
of induced hyperstimulation, the neovascularization involves
multiple follicles. In this case, VEGF production may overflow
the ovarian capillary bed, spill over into the peritoneal cavity
and promote the formation of ascites. This phenomenon
explains the moderate to extreme haemoconcentration and
hyperviscosity observed in severe OHSS. As suggested pre-
viously (McClure et al, 1994), the measurement of VEGF in
the plasma or urine of patients at risk of OHSS would probably
improve the safety of IVF and related procedures. Moreover,
the stasis of venous blood flow in the pelvic brim and the
lower limb is favoured by abdominal distension.
At present, many research groups are focusing their attention
on endothelial cell changes and cascade coagulation. Stress-
induced leukocytosis is a common finding during severe OHSS.
As shown in the umbilical vein, endothelial monolayer cells
may be injured by the activation of polymorphonuclear leuko-
cytes, releasing a protease which could impair the fibrinolytic
potential of the endothelium (Pintucci et al, 1993). These
lesions favour the exposition of a highly thrombogenic extra-
cellular matrix. Blood flow in the damaged vessels promotes
adhesion and the spreading of platelets on the surface of this
matrix (Kolpakov et al., 1994).
The extrinsic coagulation pathway is triggered by endothelial
cell procoagulant activity. This activity is involved in thrombo-
genesis associated with OHSS and seems to be independent
of oestradiol and progesterone plasma concentrations.
Independent of the endothelium-blood interface, humoral
modifications of haemostasis factors are associated with high
plasma concentrations of oestradiol. When the coagulation
cascade is triggered, an oestrogen-induced hypercoagulable
state is generated by increased activities of several factors
(factor Vm, von Willebrand factor and fibrinogen) and by
decreased activities of antithrombin HI and protein C (Massafra
et al., 1993). The decreased activity of factor VII may be
interpreted as a relative protective mechanism operating at
very high plasma concentrations of oestrogen (Bremme et al,
1994). Currently used laboratory tests such as Quick time,
accelerated partial thrombin time, fibrinogen or platelet count
have all failed to identify a hypercoagulable state. Whole
blood clotting time and whole blood clot lysis time, as used
by Aune et al (1993), are not available for routine investigation.
In-vitro clot-based methods, testing the visco-elastic properties
of the thrombus, are sensitive methods which are used to
investigate the blood hypercoagulability associated with
ovarian stimulation. However, they have failed to describe the
platelet and vascular endothelium interface.
In conclusion, whether thrombogenesis is dependent upon
important hormonal changes induced by stimulation, vascular
damage, haemostasis modifications or all these factors is
not clear.
Conclusion
In our reported case, arterial thrombosis occurred even though
a moderate OHSS was present Although a moderate OHSS
was predictable, the risk of arterial thrombosis was not This
emphasizes the importance of informing patients about possible
complications associated with stimulation.
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